Exam 11: Selective Genetic Sensitivity of Cells to Toxicants
Exam 1: Biological Research in Toxicology3 Questions
Exam 2: Development of the Field of Toxicology3 Questions
Exam 3: Toxicology Terms and How They Relate to Organisms8 Questions
Exam 4: Hazard, Exposure, and Risk Modeling9 Questions
Exam 5: Absorption and Transport of Toxicants Through Membranes: Toxic Damage to Membranes5 Questions
Exam 6: Receptor-Mediated Toxicities on the Outside of Cells4 Questions
Exam 7: Detoxication and Activation by Cells: Metabolism of the Original Toxicant9 Questions
Exam 8: Damage to Cytosolic and Endoplasmic Reticulum Activities6 Questions
Exam 9: Damage to Mitochondrial and Chloroplast Activities5 Questions
Exam 10: Damage to Nuclear Structuresdna: Mutagenesis and Carcinogenesis7 Questions
Exam 11: Selective Genetic Sensitivity of Cells to Toxicants5 Questions
Exam 12: Nutritional Toxicity and Sensitivity7 Questions
Exam 13: Routes of Administration and Which Organs Are Most Likely Impacted Based on Route and Toxicokinetic Models8 Questions
Exam 14: Forensic Toxicity Testing4 Questions
Exam 15: The Skin and Eye: Most Likely Exposure Routes and Toxicities Due to Contact Exposure and Dose Toxicities4 Questions
Exam 16: Gastrointestinal System Toxicity and Oral Exposure Gi Tract, Pancreas, Liver7 Questions
Exam 17: The Lung and Gill Exposures Representing Toxic Concentrationsmodel for Environmental Toxicology4 Questions
Exam 18: The Cardiovascular System As Conduit for a Dose Becoming a Dosage: Exposure and Toxicities4 Questions
Exam 19: Bone Marrow and Immune Organ Toxicity Via Lymphatic and Blood Transport10 Questions
Exam 20: The Nervous System and Exposure to Lipophilic Toxicants or Transported Neurotoxic Agents5 Questions
Exam 21: Toxicity to Neuroendocrine Organs and Endocrine Disruption4 Questions
Exam 22: Toxicity to Reproductive Organs and Developmental Toxicity5 Questions
Exam 23: Excretion of Hydrophilic Toxicants and Metabolites and Kidney Toxicity5 Questions
Exam 24: Dispersion Modeling in Air, Water, and Soil: Likely Route of Exposure and Most Sensitive Organism Based on Dispersion and Concentration3 Questions
Exam 25: Agricultural Chemicals Pesticides and Fertilizers: Exposure and Impacts5 Questions
Exam 26: Industrial Chemicals That Biodegrade: Organic Chemical Exposures and Impacts5 Questions
Exam 27: Ndustrial Chemicals That Change Lipophilicity but Do Not Biodegrade: Metal Impacts4 Questions
Exam 28: Industrial Chemicals That Cause Atmospheric Changes and Direct Versus Indirect Toxicity: Gases, Vapors, Aerosols, and Radiation5 Questions
Exam 29: Toxicity of Pharmaceuticals and Personal Care Products Ppcps Into Water2 Questions
Exam 30: Venoms and Injection Toxicity Versus Poisonous Animals or Cells and Ingestion or Contact Toxicity5 Questions
Exam 31: Poisonous Plants or Plant Cells and Ingestion or Contact Toxicity5 Questions
Select questions type
People with polymorphisms in the ALDH1 gene don't enjoy liquor. Why?
Free
(Essay)
4.8/5
(37)
Correct Answer:
The acetaldehyde they form from ethanol does not get metabolized rapidly to a less toxic form.
How can a CYP polymorphism OR a GSTM polymorphism lead to an increase in toxicity of a compound?
Free
(Essay)
4.7/5
(32)
Correct Answer:
Increased activation of environmental or industrial toxicant activation (such as PAHs in cigarette smoke) or inability to conjugate toxic metabolites (such as the quinone imine of acetaminophen) may lead to increased toxicity and it may not be clear initially without genetic and metabolic analyses why the person or a specific population responded more strongly to a toxicant or toxicant mixture.
Why would polymorphisms of the OAT1B1 protein lead to liver cell hypersensitivity and polymorphisms of the MRP2 protein lead to liver cell hyposensitivity to the cholesterol lowering drug pravastatin?
Free
(Essay)
4.8/5
(44)
Correct Answer:
OATP1B1 transported polymorphisms leads to increased plasma concentrations of the metabolite and toxicity of the statins. The opposite is true for those with polymorphisms encoding for a the multidrug resistance-associated protein 2.
Women with the BRCA1 or BRCA2 gene polymorphism/mutation are known to have poor outcomes for prevention of breast cancer. How might alterations of other genes lead to similar prognoses?
(Essay)
4.9/5
(33)
Why do people with certain immune gene polymorphisms have dermal toxicity?
(Essay)
4.8/5
(31)
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)